Drug design for cardiac treatment by control of K channel
通过控制 K 通道进行心脏治疗的药物设计
基本信息
- 批准号:10044259
- 负责人:
- 金额:$ 3.26万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The delayed rectifier KィイD1+ィエD1 current (IィイD2KィエD2) is one of the most important currents responsible for repolarization of cardiac action potential. IィイD2KィエD2 is composed of two distinctive components : a rapidly activating component, IィイD2KrィエD2, and a slowly activating component, IィイD2KsィエD2. Most of the Class III drugs currently used, such as d-sotalol, dofetilide, sematilide and MS-551 preferentially block IィイD2KrィエD2. Potassium channel genes which encode IィイD2KrィエD2 and IィイD2KsィエD2, are HERG and KVLQT1/minK, respectively. In this study, we examined the modulation of various class III antiarrhythmic drugs on HERG and KVLQT1/minK currents.We have previously shown that vesnarinone, a cardiotonic agent, produced a frequency-dependent prolongation of action potential duration (APD) in rabbit ventricular myocytes. This favorable property as a class III antiarrhythmic agent has not been reported with other class III drugs. To elucidate the underlying mechanisms, we studied the effects of vesnarinone on HERG channels, and KVLQT1/minK channels in Xenopus oocytes. Vesnarinone provided a concentration-dependent inhibition on HERG current with an ICィイD250ィエD2 of 58.7±9.3 μM + 50mV (n=5). The onset of HERG block by 100μM vesnarinone at +10mV developed with a time constant of 178±15 msec (n=3). Vesnarinone at 300 M produced a minimal reduction in KVLQT1/minK current. These results suggest that 1) the prolongation in APD by vesnarinone is caused by block of HERG, but not KVLQT1/minK channels, 2) frequency-dependent prolongation of APD by vesnarinone results from the voltage-dependent binding and unbinding of the drug to HERG channels with moderate time constants, 3) inactivation gate may not interfere neither the drug binding nor unbinding when membrane voltage was altered.
延迟记录的D1+Wie D1电流ii D2K YIE D2由两个独特的组成部分组成:迅速激活的成分II D2KR IE D2和一个缓慢激活的成分II D2KS II D2。 MS-551优先块II D2KR IE D2用其他类药物的卵母细胞中的III级通道报道。 μm在 + 10mV时以178±15 msec的时间来形成(n = 3),在300 m的e中产生了最小的kvlqt1/mink电流。 kVLQT1/MINK通道通过vensnarine通过电压依赖性结合的结合并将HERG与中等时间常数的HERG对HERG通道的解开,3)灭活门可能不会改变GRANE时的药物结合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
LEE Jong-Kook,NISHIYAMA Atsushi,KAMBE Fukushi,SEO Hisao,TAKEUCHI Susumu,KAMIYA Kaichiro: "Downregulation of voltage-gated K+ channels in rat heart with right ventricular hypertrophy"American Journal of Physiology. 277. 1725-1731 (1999)
LEE Jong-Kook、NISHIYAMA Atsushi、KAMBE Fukushi、SEO Hisao、TAKEUCHI Susumu、KAMIYA Kaichiro:“右心室肥大大鼠心脏电压门控 K 通道的下调”美国生理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LEE Jong-Kook, NISHIYAMA Atsushi, KAMBE Fukushi, SEO Hisato, TAKEUCHI Susumu, KAMIYA Kaichiro: "Downregulation of voltage-gated K+ channels in rat heart with right ventricular hypertrophy"American Journal of Physiology. 277. 1725-1731 (1999)
LEE Jong-Kook、NISHIYAMA Atsushi、KAMBE Fukushi、SEO Hisato、TAKEUCHI Susumu、KAMIYA Kaichiro:“右心室肥大大鼠心脏中电压门控 K 通道的下调”美国生理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
KADA Kenji, YASUI Kenji, NARUSE Kenji, KAMIYA Kaichiro, et al.: "Orientation change change of cardiocytes induced by cyclic stretch stimulation : Time dependency and involvement of protein kinases"Journal of Molecular and Cellular Cardiology. 31. 247-259
KADA Kenji、YASUI Kenji、NARUSE Kenji、KAMIYA Kaichiro 等人:“循环拉伸刺激诱导的心肌细胞的方向变化:时间依赖性和蛋白激酶的参与”分子和细胞心脏病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
神谷 香一郎: "循環器病への挑戦シリーズXIII,「心房細動の最近の話題」"ライフメディコム. 13 (1999)
Koichiro Kamiya:“挑战心血管疾病系列 XIII,‘心房颤动的最新话题’”Life Medicom 13 (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LEE Jong-KooK, NISHIYAMA Atsushi, KAMBE Fukushi, SEO, Hisao, TAKEUCHI Susumu, KAMIYA Kaichiro, KODAMA Itsuo, TOYAMA Junji: "Downregulation of voltage-gated K+ channels in rat heart with right ventricular hypertrophy"American Journal of Physiology 277 (Hea
LEE Jong-KooK、NISHIYAMA Atsushi、KAMBE Fukushi、SEO、Hisao、TAKEUCHI Susumu、KAMIYA Kaichiro、KODAMA Ituo、TOYAMA Junji:“右心室肥大大鼠心脏中电压门控 K 通道的下调”美国生理学杂志 277(Hea
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAMIYA Kaichiro其他文献
不整脈の病態生理(小室一成(編))
心律失常的病理生理学(Kamushige Komuro(编))
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:0
- 作者:
NIWA Noriko;YASUI Kenji;OPTH OF Tobias;TAKEMURA Haruki;SHIMIZU Atsuya;HORIBA Mitsuru;LEE Jong-Kook;HONJO Haruo;KAMIYA Kaichiro;KODAMA Itsuo;神谷 香一郎;神谷 香一郎;神谷 香一郎;Nukiwa M;神谷香一郎;Fujiwara T;Kamiya K.;Inoue A;神谷 香一郎 - 通讯作者:
神谷 香一郎
TRPC chanel inhibitors reduce vulnerability to atrial fibrillaion in acutely-inflated rabbit atria.
TRPC 通道抑制剂可降低兔心房急性膨胀时发生心房颤动的可能性。
- DOI:
- 发表时间:
2008 - 期刊:
- 影响因子:0
- 作者:
YAMAMOTO Mitsuru;UEDA Norihiro;HORIBA Mitsuru;HONJO Haruo;KAMIYA Kaichiro;KODAMA Itsuo;SOKABE Masahiro - 通讯作者:
SOKABE Masahiro
Partial blockade of IK_1 destabilizes the rotation center of spiral wave reentry without enhancement of wavefront-tail interaction in the arm
部分封锁 IK_1 会破坏螺旋波折返旋转中心的稳定性,而不会增强手臂中的波前-尾部相互作用
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
KUSHIYAMA Yasunori;HONJO Haruo;NIWA Ryoko;TAKANARI Hiroki;YAMAZAKI Masatoshi;TAKEMOTO Yoshio;UEDA Norihiro;OKUNO Yusuke;SAKUMA Ichiro;KODAMA Itsuo;KAMIYA Kaichiro - 通讯作者:
KAMIYA Kaichiro
Urinary type IV collagen is related to left ventricular diastolic function and brain natriuretic peptide in hypertensive patients with prediabete
高血压合并糖尿病前期患者尿IV型胶原与左心室舒张功能及脑钠肽相关
- DOI:
10.1016/j.jdiacomp.2014.08.005 - 发表时间:
2014 - 期刊:
- 影响因子:3
- 作者:
IIDA Masato;ISHIGURO Yuko S.;YAMAZAKI Masatoshi;UEDA Norihiro;HONJO Haruo;KAMIYA Kaichiro - 通讯作者:
KAMIYA Kaichiro
Multicenter Phase I Study of Repeated Intratumoral Delivery of Adenoviral p53 (ADVEXIN) in Patients with Advanced Non-Small Cell Lung Cancer.
在晚期非小细胞肺癌患者中重复瘤内注射腺病毒 p53 (ADVEXIN) 的多中心 I 期研究。
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
NIWA Noriko;YASUI Kenji;OPTH OF Tobias;TAKEMURA Haruki;SHIMIZU Atsuya;HORIBA Mitsuru;LEE Jong-Kook;HONJO Haruo;KAMIYA Kaichiro;KODAMA Itsuo;神谷 香一郎;神谷 香一郎;神谷 香一郎;Nukiwa M;神谷香一郎;Fujiwara T;Kamiya K.;Inoue A;神谷 香一郎;神谷 香一郎;shimoto O;Inoue A;Nukiwa M;Fujiwara T - 通讯作者:
Fujiwara T
KAMIYA Kaichiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAMIYA Kaichiro', 18)}}的其他基金
Molecular mechanism and clinical trial center for the drug-induced QT prolongation syndrome
药物引起的QT间期延长综合征的分子机制及临床试验中心
- 批准号:
16390222 - 财政年份:2004
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms and its prevention of drug-induced long QT syndrome
药物性长QT综合征的分子机制及其预防
- 批准号:
14370222 - 财政年份:2002
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Polymorphism of cardiac K^+ channel gene and hyperactivity of drugs
心脏K^通道基因多态性与药物亢进
- 批准号:
12670656 - 财政年份:2000
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modulation of cardiac potassium channels in pathological conditions and developments
心脏钾通道在病理状况和发展中的调节
- 批准号:
09670710 - 财政年份:1997
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on the mechanisms of antiarrhythmic agents through gene expression of cardiac potassium channels
心脏钾通道基因表达的抗心律失常药物作用机制研究
- 批准号:
07670774 - 财政年份:1995
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of antiarrhythmic drugs via gene expression
抗心律失常药物通过基因表达的机制
- 批准号:
05670604 - 财政年份:1993
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
选择性心房钠通道阻滞剂的鉴选及其抗心房颤动作用的机制研究
- 批准号:81370290
- 批准年份:2013
- 资助金额:75.0 万元
- 项目类别:面上项目
延迟整流钾通道IKr和IKs双重阻滞剂的合理药物设计、合成与药效学评价研究
- 批准号:30901836
- 批准年份:2009
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
具有抗心律失常作用药物阻断人心肌克隆的HERG钾通道的分子靶位和结构-功能关系研究
- 批准号:30572181
- 批准年份:2005
- 资助金额:26.0 万元
- 项目类别:面上项目
缝隙连接:抗心律失常药物作用新靶点和机制研究
- 批准号:30270542
- 批准年份:2002
- 资助金额:19.0 万元
- 项目类别:面上项目
相似海外基金
Peripherally restricted α2/δ-1 subunit ligands that modulate CaV channel gating as novel antiarrhythmic drugs
外周限制的α2/β-1亚基配体作为新型抗心律失常药物调节CaV通道门控
- 批准号:
9406676 - 财政年份:2017
- 资助金额:
$ 3.26万 - 项目类别:
Development of new antiarrhythmic drugs alternative to beta blocker therapy
开发替代β受体阻滞剂治疗的新型抗心律失常药物
- 批准号:
15K18973 - 财政年份:2015
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Improving Diagnosis and Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: Integrating Clinical and Basic Science
改善儿茶酚胺能多形性室性心动过速的诊断和治疗:临床与基础科学的结合
- 批准号:
332035 - 财政年份:2015
- 资助金额:
$ 3.26万 - 项目类别:
Operating Grants
Molecular determinants of atrial fibrillation susceptibility and progression.
房颤易感性和进展的分子决定因素。
- 批准号:
333137 - 财政年份:2015
- 资助金额:
$ 3.26万 - 项目类别:
Operating Grants
Mechanisms and consequences of atrial ionic remodeling
心房离子重构的机制和后果
- 批准号:
238533 - 财政年份:2011
- 资助金额:
$ 3.26万 - 项目类别:
Operating Grants